These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38275711)

  • 21. Integrated serum pharmacochemistry and network pharmacology analyses reveal the bioactive metabolites and potential functional mechanism of ground cherry (Physalis pruinosa L.) in treatment of type 2 diabetes mellitus in rats.
    Mahana A; Hammoda HM; Khalifa AA; Elblehi SS; Harraz FM; Shawky E
    J Ethnopharmacol; 2023 Jan; 300():115750. PubMed ID: 36162547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined Network Pharmacology and Molecular Docking to Verify the Treatment of Type 2 Diabetes with
    Mao J; Wang G; Yang L; Tan L; Tian C; Tang L; Fang L; Mu Z; Zhu Z; Li Y
    Comput Math Methods Med; 2023; 2023():9150324. PubMed ID: 36820318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of the potential mechanism of the Shugan Xiaozhi decoction for the treatment of nonalcoholic fatty liver disease based on network pharmacology, molecular docking and molecular dynamics simulation.
    Yang R; Yang H; Jiang D; Xu L; Feng L; Xing Y
    PeerJ; 2022; 10():e14171. PubMed ID: 36389420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Network pharmacology, molecular docking and experimental validation to elucidate the anti-T2DM mechanism of Lanxangia tsaoko.
    Wang Z; Li R; Chen X; Ren H; Wang C; Min R; Zhang X
    Fitoterapia; 2024 Oct; 178():106117. PubMed ID: 38996878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Network pharmacology-based prediction and validation of the active ingredients and potential mechanisms of the Huangxiong formula for treating ischemic stroke.
    Zhao S; Zhang P; Yan Y; Xu W; Li J; Wang L; Wang N; Huang Y
    J Ethnopharmacol; 2023 Aug; 312():116507. PubMed ID: 37080367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipidomics of the erythrocyte membrane and network pharmacology to explore the mechanism of mangiferin from Anemarrhenae rhizoma in treating type 2 diabetes mellitus rats.
    Zhong Y; Xu Y; Tan Y; Zhang X; Wang R; Chen D; Wang Z; Zhong X
    J Pharm Biomed Anal; 2023 Jun; 230():115386. PubMed ID: 37044004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigation of the Potential Mechanism of
    Zhang X; Li X; Li H; Zhou M; Zhang Y; Lai W; Zheng X; Bai F; Zhang J
    Evid Based Complement Alternat Med; 2023; 2023():4934711. PubMed ID: 36818229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploration of the Molecular Mechanism of Polygonati Rhizoma in the Treatment of Osteoporosis Based on Network Pharmacology and Molecular Docking.
    Zhao J; Lin F; Liang G; Han Y; Xu N; Pan J; Luo M; Yang W; Zeng L
    Front Endocrinol (Lausanne); 2021; 12():815891. PubMed ID: 35069454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular mechanism of Ginkgo biloba in treating type 2 diabetes mellitus combined with non-alcoholic fatty liver disease based on network pharmacology, molecular docking, and experimental evaluations.
    Xu S; Tang L; Qian X; Wang Y; Gong J; Yang H; Su D
    J Food Biochem; 2022 Dec; 46(12):e14419. PubMed ID: 36121703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrated plasma pharmacochemistry and network pharmacology to explore the mechanism of Gerberae Piloselloidis Herba in treatment of allergic asthma.
    Zhou K; Lu D; You J; Liu T; Sun J; Lu Y; Pan J; Li Y; Liu C
    J Ethnopharmacol; 2022 Nov; 298():115624. PubMed ID: 35970314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic Evaluation of the Mechanisms of Mulberry Leaf (Morus alba Linne) Acting on Diabetes Based on Network Pharmacology and Molecular Docking.
    Wu Q; Hu Y
    Comb Chem High Throughput Screen; 2021; 24(5):668-682. PubMed ID: 32928080
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Peng C; Li J; Ke X; Liu F; Huang KE
    Ann Med; 2023 Dec; 55(1):2200258. PubMed ID: 37096878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
    Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
    J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigating the Mechanism of Rhizoma Coptidis-Eupatorium fortunei Medicine in the Treatment of Type 2 Diabetes Based on Network Pharmacology and Molecular Docking.
    Li H; Luo D; Wei R; Sun M; Zhang X; Deng H; Bian W; Wei H; Huang Y
    Biomed Res Int; 2022; 2022():7978258. PubMed ID: 36452059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systems pharmacology-based drug discovery and active mechanism of phlorotannins for type 2 diabetes mellitus by integrating network pharmacology and experimental evaluation.
    Chen J; Li P; Ye S; Li W; Li M; Ding Y
    J Food Biochem; 2022 Dec; 46(12):e14492. PubMed ID: 36385377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of the Mechanism of Astragali Radix in Treating Type 2 Diabetes Mellitus and Its Renal Protection Based on Enzyme Activity, Network Pharmacology, and Experimental Verification.
    Li C; Zhang K; Liu L; Shen J; Wang Y; Tan Y; Feng X; Liu W; Zhang H; Sun J
    Molecules; 2023 Dec; 28(24):. PubMed ID: 38138520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring novel targets of sitagliptin for type 2 diabetes mellitus: Network pharmacology, molecular docking, molecular dynamics simulation, and SPR approaches.
    Qi JH; Chen PY; Cai DY; Wang Y; Wei YL; He SP; Zhou W
    Front Endocrinol (Lausanne); 2022; 13():1096655. PubMed ID: 36699034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of bioactive compounds and potential mechanisms of scutellariae radix-coptidis rhizoma in the treatment of atherosclerosis by integrating network pharmacology and experimental validation.
    Ji L; Song T; Ge C; Wu Q; Ma L; Chen X; Chen T; Chen Q; Chen Z; Chen W
    Biomed Pharmacother; 2023 Sep; 165():115210. PubMed ID: 37499457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring the targets and molecular mechanism of glycyrrhetinic acid against diabetic nephropathy based on network pharmacology and molecular docking.
    Meng FD; Yuan L; Xu DJ; Che MY; Hou SZ; Lu DD; Liu WJ; Nan Y
    World J Diabetes; 2023 Nov; 14(11):1672-1692. PubMed ID: 38077799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploring the mechanism of aloe-emodin in the treatment of liver cancer through network pharmacology and cell experiments.
    Zhu M; He Q; Wang Y; Duan L; Rong K; Wu Y; Ding Y; Mi Y; Ge X; Yang X; Yu Y
    Front Pharmacol; 2023; 14():1238841. PubMed ID: 37900162
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.